iCAD Corp (ICAD) - שיעור רווח גולמי

iCAD, Inc. (ICAD) bases its business on the implementation of AI algorithms for early breast cancer diagnosis, which streamlines the workflow for radiologists. The gross margin ratio demonstrates the pace of profitability recovery, while 84.40 captures the current value of the indicator. Stable cloud capacity and regular software upgrades eliminate server depreciation. The high accuracy of its solutions allows the company to maintain pricing power over its products for clinics.
פילוחי מדדים מקיפים ואנליטיקה עבור iCAD, Inc. (ICAD)

Gross margin serves as a fundamental efficiency filter, determining the profit share after deducting direct production costs. Analyzing the gross profit level relative to revenue allows for an assessment of management's ability to control cost of goods sold and counter resource inflation. For iCAD, Inc. (ICAD), this indicator reflects the profitability of the synergy between AI diagnostics and radiation therapy hardware systems when supplied to medical centers.